Jazz Pharmaceuticals plc is a biopharmaceutical company that researches, produces, and markets drugs globally, with operations centered in the United States and Europe. The company's marketed products treat neurological conditions including narcolepsy and epilepsy, as well as various cancers such as leukemia, lung cancer, and glioma. Its pipeline includes multiple investigational therapies in clinical development for oncology and neurological indications, supported by partnerships with several biotechnology and pharmaceutical firms.

entry readiness 58 · MODERATE · exit proximity 0

Value area 225.37–253.56 · 90% of 120d volume overhead · heavy supply